Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Study of the Progression of Chronic Cardiovascular Conditions

A Non-interventional Observational Study of the Sustained Use of Prolaio Digital Health Devices to Monitor the Natural History of Chronic Cardiovascular Conditions in Ambulatory Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study will collect physiologic data in patients with cardiovascular conditions and observe the natural history of those conditions for research purposes.

Who May Be Eligible (Plain English)

Who May Qualify: - 18 years of age and older - Ability to understand study assessments and give willing to sign a consent form to data collection - Ability to comply with the study protocol - Ability to understand and respond to instructions in English - Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but not limited to: HF, AS, HCM, HTN, DCM, etc. - Resides in the United States Who Should NOT Join This Trial: - Allergy to adhesive used in biosensor patch - Life threatening disease process outside of area under study, such as actively treated cancer or pre/post-transplant such as hepatic failure; end-stage renal disease. - Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV - Self-reported weight of 400 pounds or greater Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * 18 years of age and older * Ability to understand study assessments and give informed consent to data collection * Ability to comply with the study protocol * Ability to understand and respond to instructions in English * Has diagnosis of qualifying Cardiovascular Disease(s) (CVD) including but not limited to: HF, AS, HCM, HTN, DCM, etc. * Resides in the United States Exclusion Criteria: * Allergy to adhesive used in biosensor patch * Life threatening disease process outside of area under study, such as actively treated cancer or pre/post-transplant such as hepatic failure; end-stage renal disease. * Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV * Self-reported weight of 400 pounds or greater

Locations (1)

Prolaio
Chicago, Illinois, United States